Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The objective is to compare efficacy and safety of masitinib at 12 mg/kg/day to sunitinib at 50 mg/day in treatment of patients with gastro-intestinal stromal tumor resistant to imatinib.
Critère d'inclusion
- Gastro Intestinal Stromal Tumor